Search

Objectives: To describe the long‐term perspective regarding prevalence of risk factors, secondary stroke prevention, and lifestyle indices after stroke. Methods: From a population‐based one‐year cohort (n = 416), we performed an observational study of 145 survivors at 16 months and 10 years after stroke (age 27‐97 years) regarding secondary prevention including reaching acceptable treatment goals; nutritional status with focus on underweight; and the lifestyle indices: living situation, level of dependence, and self‐assessed health condition. Results: Ten years after stroke, 50% of the subjects with hypertension diagnosis and 55% of those without hypertension diagnosis were within the blood pressure goal <140/90 compared with 32% (P = .008) and 37% (N.S.) at 16 months. Acceptable HbA1c levels among subjects with diabetes mellitus diagnosis increased from 35% to 45% (N.S.). Among those without diabetes diagnosis, satisfactory HbA1c levels decreased from 98% to 79% (P < .001). Underweight increased from 9% to 17% (P = .019). Among patients with cerebral infarction, the prevalence of atrial fibrillation increased from 22% to 29% (P = .004), and treatment with oral anticoagulants from 75% to 78% (N.S.). Acceptable LDL cholesterol levels increased from 59% to 80% (P = .033) among subjects on lipid lowering treatment, and from 18% to 40% among untreated (P = .010). At 10 years, 90% still lived in their own home. Health condition was reported as good/very good/excellent by 65%. Age, female sex, and living situation were associated with intensity of secondary prevention measures and underweight. Conclusions: The proportion of individuals within treatment goals improved over time, but secondary prevention still needed additional consideration 10 years after stroke. [ABSTRACT FROM AUTHOR]

Objectives Post-stroke cognitive impairment ( PSCI) has considerable impact on patients and society. However, long-term studies on PSCI are scarce and may be influenced by assessment methods and selection bias. We aimed to (i) assess the prevalence of long-term PSCI; (ii) compare two common cognitive assessment instruments; and (iii) compare cognitive function of long-term stroke survivors with non-stroke persons. Methods Mini-Mental State Examination ( MMSE) and Montreal Cognitive Assessment (Mo CA) were administered to 10-year survivors from a population-based cohort of first-ever stroke patients included in the Lund Stroke Register, Sweden, in 2001-2002. PSCI was defined as MMSE<27 and/or Mo CA<25 and severe cognitive impairment as MMSE<23. Age- and sex-matched non-stroke control subjects who had performed MMSE (but not Mo CA) were recruited from the longitudinal population study 'Good Ageing in Skåne.' The odds of having cognitive impairment for stroke survivors compared to controls were examined with logistic regression analyses adjusting for education. Results Of 145 stroke survivors after 10 years, 127 participated. MMSE showed PSCI in 46%, whereas Mo CA displayed PSCI in 61%. Among the stroke survivors with Mo CA<25, 35% had MMSE≥27 ( P<.001). The odds of having severe cognitive impairment defined as MMSE<23 were higher among the stroke survivors compared to 354 controls (education-adjusted; OR=2.5; P=.004). Conclusions Post-stroke cognitive impairment was prevalent among 10-year stroke survivors, and the odds of having severe cognitive impairment were higher among the stroke survivors compared to non-stroke persons. The burden of long-term PSCI might have been underestimated previously, and Mo CA may be more suitable than MMSE to detect long-term PSCI. [ABSTRACT FROM AUTHOR]

Background and purpose The Coronary Artery Disease Genome-Wide Replication and Meta-Analysis Study (CARDIoGRAM) reported 25 single-nucleotide polymorphisms (SNPs) on 15 chromosomes to be associated with coronary artery disease ( CAD) risk. Because common vascular risk factors are shared between CAD and ischaemic stroke ( IS), these SNPs may also be related to IS overall or one or more of its pathogenetic subtypes. Methods We performed a candidate gene study comprising 3986 patients with IS and 2459 control subjects. The 25 CAD-associated SNPs reported by CARDIoGRAM were examined by allelic association analysis including logistic regression. Weighted and unweighted genetic risk scores ( GRSs) were also compiled and likewise analysed against IS. We furthermore considered the IS main subtypes large-vessel disease ( LVD), small-vessel disease and cardioembolic stroke [according to Trial of Org 10172 in Acute Stroke Treatment ( TOAST)] separately. Results SNP rs4977574 on chromosome 9p21.3 was associated with overall IS [odds ratio ( OR) = 1.12; 95% confidence interval ( CI): 1.04-1.20; P = 0.002] as well as LVD ( OR = 1.36; 95% CI: 1.13-1.64; P = 0.001). No other SNP was significantly associated with IS or any of its main subtypes. Analogously, the GRSs did not show any noticeable effect. Conclusions Besides the previously reported association with SNPs on chromosome 9p21, this study did not detect any significant association between IS and CAD-susceptible genetic variants. Also, GRSs compiled from these variants did not predict IS or any pathogenetic IS subtype, despite a total sample size of 6445 participants. [ABSTRACT FROM AUTHOR]

Background and purpose Clinical stroke trials with stem cell-based approaches aiming for trophic actions, modulation of inflammation and neuroprotection are ongoing. However, experimental studies also suggest that neuronal replacement by grafted neural stem cells ( NSCs) and possibly by endogenous NSCs from the subventricular zone ( SVZ) may restore function in the stroke-damaged striatum. To evaluate the potential clinical impact of these findings, we analyzed the spatial relationship of infarcts to the SVZ and the proportion of individuals with striatal lesions in a consecutive series of ischaemic stroke patients. Methods Patients aged 20-75 years with first-ever ischaemic stroke underwent DW- MRI of the brain within 4 days after stroke onset. We analyzed location, size, number of acute focal ischaemic abnormalities and their spatial relationship to the SVZ. Stroke severity was assessed using NIH Stroke Scale ( NIHSS). Results Of 108 included patients, the distance from the nearest margin of the infarct(s) to the SVZ was ≤2 mm in 51/102 patients with visible ischaemic lesions on DW- MRI. Twenty-four patients had involvement of striatum. Eight of these had predominantly striatal lesions, that is >50% of the total ischaemic lesion volume was located in caudate nucleus and/or putamen. These 8 patients had a median NIHSS of 3. Conclusions Many stroke patients have infarcts located close to the SVZ, providing some supportive evidence that optimized endogenous neurogenesis may have therapeutic potential. However, predominantly striatal infarcts are rare and tend to give mild neurological deficits, indicating that striatum should not be the primary target for neuronal replacement efforts in humans. [ABSTRACT FROM AUTHOR]